Cover Story
No Patient Left Behind: Expanding Semaglutide’s Reach
Recent studies from Endocrine Society journals have shown that GLP-1 RAs are not only successful in reducing obesity, but they have positiv...
Features
Moving Forward: The Future of GLP-1 Therapies
The Endocrine Society recently held a virtual Science Writers Conference dedicated to the current landscape and future horizons of ...Closing the Obesity Diagnosis Gap: A New EHR-Based Measure Could Improve Population Health Outcomes
A new obesity measure championed by authors of a recent Journal of Clinical Endocrinology & Metabolism paper could move the ne...
